LEVO Trademark

Trademark Overview

On Tuesday, November 21, 2017, a trademark application was filed for LEVO with the United States Patent and Trademark Office. The USPTO has given the LEVO trademark a serial number of 87980901. The federal status of this trademark filing is REGISTERED as of Tuesday, June 18, 2019. This trademark is owned by Levo Therapeutics, Inc.. The LEVO trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific research and development; research and development in the pharmaceutical and biotechnology fields; development of pharmaceutical preparations and medicines; medical and scientific research for developing and providing programs and questionnaires for disease-specific assessment and care
levo

General Information

Serial Number87980901
Word MarkLEVO
Filing DateTuesday, November 21, 2017
Status700 - REGISTERED
Status DateTuesday, June 18, 2019
Registration Number5783388
Registration DateTuesday, June 18, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 11, 2018

Trademark Statements

Goods and ServicesScientific research and development; research and development in the pharmaceutical and biotechnology fields; development of pharmaceutical preparations and medicines; medical and scientific research for developing and providing programs and questionnaires for disease-specific assessment and care

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, December 4, 2017
Primary Code042
First Use Anywhere DateMonday, June 4, 2018
First Use In Commerce DateMonday, June 4, 2018

Trademark Owner History

Party NameLevo Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSkokie, IL 60077
Party NameLevo Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSkokie, IL 60077
Party NameLevo Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSkokie, IL 60077

Trademark Events

Event DateEvent Description
Wednesday, March 7, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, November 24, 2017NEW APPLICATION ENTERED
Monday, December 4, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, March 6, 2018ASSIGNED TO EXAMINER
Wednesday, March 7, 2018NON-FINAL ACTION E-MAILED
Wednesday, March 7, 2018NON-FINAL ACTION WRITTEN
Wednesday, July 11, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, July 26, 2018ASSIGNED TO LIE
Tuesday, July 31, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, July 31, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, August 2, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 22, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 11, 2018PUBLISHED FOR OPPOSITION
Tuesday, September 11, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 6, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, April 26, 2019TEAS STATEMENT OF USE RECEIVED
Friday, April 26, 2019TEAS REQUEST TO DIVIDE RECEIVED
Friday, April 26, 2019DIVISIONAL REQUEST RECEIVED
Monday, May 13, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, May 15, 2019DIVISIONAL PROCESSING COMPLETE
Friday, May 17, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, June 18, 2019REGISTERED-PRINCIPAL REGISTER
Monday, January 31, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, April 26, 2019USE AMENDMENT FILED
Wednesday, May 15, 2019STATEMENT OF USE PROCESSING COMPLETE
Thursday, May 16, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, January 31, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, January 31, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, June 18, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, November 28, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, November 28, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, November 28, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Related Keywords

levo research development scientific pharmaceutical disease questionnaires care programs assessment specific